Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hamilton Thorne Ltd HTLZF


Primary Symbol: T.HTL

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and... see more

Recent & Breaking News (TSX:HTL)

Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2024

Newsfile 8 days ago

Hamilton Thorne Provides Update on Going Private Transaction

Newsfile October 17, 2024

Hamilton Thorne Announces Shareholder Approval of Going Private Transaction

GlobeNewswire September 17, 2024

Hamilton Thorne Announces Mailing of Meeting Materials and Receipt of Interim Order in Respect of Going Private Transaction

GlobeNewswire August 26, 2024

Hamilton Thorne Reports Revenue for the Quarter and Six Months Ended June 30, 2024, and Confirms Annual Guidance

GlobeNewswire August 14, 2024

Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 2024

GlobeNewswire August 7, 2024

Hamilton Thorne Announces Agreement to be Acquired by Astorg for CAD$2.25 Per Share in Cash

GlobeNewswire July 22, 2024

Hamilton Thorne Announces Voting Results of 2024 Annual Meeting

GlobeNewswire June 11, 2024

Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter Ended March 31, 2024, and Confirms Annual Guidance

GlobeNewswire May 14, 2024

Hamilton Thorne to Announce Q1 2024 Financial Results and Hold Conference Call on May 14, 2024

GlobeNewswire May 6, 2024

Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Newsfile April 10, 2024

Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023

GlobeNewswire March 27, 2024

Hamilton Thorne to Announce Q4 and Full Year 2023 Financial Results and Hold Conference Call on March 27, 2024

GlobeNewswire March 21, 2024

Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin as President and CEO

GlobeNewswire December 21, 2023

Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2023

GlobeNewswire November 13, 2023

Hamilton Thorne to Announce Q3 2023 Financial Results and Hold Conference Call on November 13, 2023

GlobeNewswire November 7, 2023

RETRANSMISSION: Lytham Partners Announces KOL Panels and Participating Companies for its Fall 2023 Investor Conference

Newsfile October 16, 2023

Canadian Investment Regulatory Organization Trade Resumption - HTL

Canada NewsWire October 10, 2023

Hamilton Thorne Announces the Acquisition of Gynetics Medical Products N.V.

Newsfile October 10, 2023

Canadian Investment Regulatory Organization Trading Halt - HTL

Canada NewsWire October 10, 2023